Answers are grounded in this paper and cite their sources.
Case study shows Bayesian methods enhance treatment efficiency in obstructive sleep apnea, indicating improved subgroup detection.
Precision medicine tailors treatments to individual patient characteristics, which is especially valuable for obstructive sleep apnea (OSA), where treatment responses vary widely. Traditional trials often overlook subgroup differences, leading to suboptimal recommendations. Current approaches rely on prespecified thresholds, which may be incorrectly specified. This case study compares prespecified thresholds to two Bayesian methods: the established FK‐BMA (free‐knot Bayesian model averaging) method, and its novel variant, FK. The FK approach retains the flexibility of free‐knot splines but omits variable selection, providing stable, interpretable models. Using biomarker data from large studies, this design identifies subgroups dynamically, allowing early trial termination or enrollment adjustments. Simulation results—motivated by real‐world biomarker distributions and clinical constraints—show that under conditions of limited signal‐to‐noise ratio and limited candidate biomarkers, FK improves efficiency and subgroup detection.
No takes yet. Share an insight, caveat, or question.
Maleyeff et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: